Impact of COVID‐19 on blood centres in Zhejiang province China

Wang, Yongjun; Han, Wenjuan; Pan, Lingling; Wang, Cuier; Liu, Yan; Hu, Wei; Zhou, Huapin; Zheng, Xiaofan

doi:10.1111/vox.12931

Cited by 139 publications

(172 citation statements)

References 12 publications

Supporting

Mentioning

137

Contrasting

Unclassified

Order By: Relevance

“…One Chinese hospital reported low numbers of blood components transfused, but did not provide the numbers of patients. 14 Hb nadir of 13.3 g/dL and median PLT count nadir of 185 × 10 9 /L. 15 These hematologic indices are similar to results from the 2005 SARS pandemic where decreases in PLT and Hb counts were mild and rarely required blood transfusion.…”

Section: Discussionsupporting

confidence: 56%

Blood transfusion utilization in hospitalized COVID‐19 patients

et al. 2020

View full text Add to dashboard Cite

Background The acute respiratory illness designated coronavirus disease 2019 (COVID‐19) was first reported in Wuhan, China, in December 2019 and caused a worldwide pandemic. Concerns arose about the impact of the COVID‐19 pandemic on blood donations and potential significant blood transfusion needs in severely ill COVID‐19 patients. Data on blood usage in hospitalized COVID‐19 patients are scarce. Study Design and Methods We performed a retrospective observational study of blood component transfusions in the first 4 weeks of COVID‐19 ward admissions. The study period began 14 days before the first COVID‐19 cohort wards opened in our hospital in March 2020 and ended 28 days afterward. The number of patients and blood components transfused in the COVID‐19 wards was tabulated. Transfusion rates of each blood component were compared in COVID‐19 wards versus all other inpatient wards. Results COVID‐19 wards opened with seven suspected patients and after 4 weeks had 305 cumulative COVID‐19 admissions. Forty‐one of 305 hospitalized COVID‐19 patients (13.4%) received transfusions with 11.1% receiving red blood cells (RBCs), 1.6% platelets (PLTs), 1.0% plasma, and 1.0% cryoprecipitate (cryo). COVID‐19 wards had significantly lower transfusion rates compared to non‐COVID wards for RBCs (0.03 vs 0.08 units/patient‐day), PLTs (0.003 vs 0.033), and plasma (0.002 vs 0.018; all p < 0.0001). Cryo rates were similar (0.008 vs 0.009, p = 0.6). Conclusions Hospitalized COVID‐19 patients required many fewer blood transfusions than other hospitalized patients. COVID‐19 transfusion data will inform planning and preparation of blood resource utilization during the pandemic.

show abstract

Section: Discussionsupporting

confidence: 56%

Blood transfusion utilization in hospitalized COVID‐19 patients

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Indeed, several countries had faced drops in their numbers of donors and donations in the early weeks of the pandemic [5][6][7]. In China and Iran for example, blood donors initially cancelled their appointments or did not show up at collection sites because of increased anxiety and worry to acquire SARS-CoV-2 [6,7]. Such reactions are in line with previous findings from SARS and avian flu outbreaks that showed that fear of infection deters donors [8,9].…”

Section: Risk Individualssupporting

confidence: 67%

“…Thus, the costs of donating for individuals are increased in terms of health risks, which may be a barrier for donors. Indeed, several countries had faced drops in their numbers of donors and donations in the early weeks of the pandemic [5][6][7]. In China and Iran for example, blood donors initially cancelled their appointments or did not show up at collection sites because of increased anxiety and worry to acquire SARS-CoV-2 [6,7].…”

Section: Risk Individualsmentioning

confidence: 99%

“…The urgent call for blood and increased media attention for Sanquin may have contributed to these new donor registrations. Attention for blood banks and blood donation in different media may be an important factor in explaining why some countries succeeded in attracting large numbers of new donors [19] whereas other countries mainly observed cancellations and no-shows [7].…”

Section: Donor Registrationsmentioning

confidence: 99%

See 1 more Smart Citation

New blood donors in times of crisis: Increased donation willingness, particularly among people at high risk for attracting SARS-CoV-2

Spekman¹,

Ramondt²,

Quee³

et al. 2020

Preprint

View full text Add to dashboard Cite

Traditionally, during crises the number of new blood donors increases. However, the current coronavirus disease (COVID-19) pandemic created additional barriers to donate due to governmental prevention measures and increased personal health risks. In this report, we examined how the pandemic affected new donor registrations in the Netherlands, especially among groups with higher risk profiles for severe COVID-19. Additionally, we explored the role of media for blood donation and new donor registrations.We analyzed new donor registrations and attention for blood donation in newspapers and on social media from January until May 2020, in comparison to the same period in 2019. After the introduction of nationwide prevention measures, several peaks in new donor registrations occurred, which coincided with peaks in media attention. Interestingly, people with a higher risk profile for COVID-19 (e.g. due to age or region of residence) were overrepresented among new registrants.In sum, the current pandemic has led to increased new blood donor registrations, despite the associated increased health risks. Time and future studies will have to tell whether these new donors are one-off ‘pandemic’ donors or if they will become regular, loyal donors.

show abstract

“…Many of the efforts and hospital resources during the COVID-19 pandemic have been oriented in the fight against COVID-19 spread and in the caring of COVID-19 patients. All the hospital activity, including TA and Transfusion Medicine in general have been quickly reorganized to face an unparalleled health emergency, with impact in blood donations and supply [22] and with great effort in the field of convalescent plasma [23][24][25]. Every clinical decision about modification of treatment plans have been shared with Clinicians and personalized based on the characteristics of patients and disease.…”

Section: Resultsmentioning

confidence: 99%

Impact of COVID-19 pandemic in the activity of a Therapeutic Apheresis unit in Italy

Colpo

Astolfi²,

Tison

et al. 2020

Transfusion and Apheresis Science

View full text Add to dashboard Cite

The recent Coronavirus Disease 2019 (COVID-19) outbreak has led to profound and rapid changes in the Italian and Veneto Region Healthcare System. This context also includes the quick reorganization which the Apheresis Unit (AU) of the Padova University Hospital, i.e. the Regional Reference Center for Therapeutic Apheresis (TA), had to face. Material and Methods: The study retrospectively evaluated the TA activity (procedures performed, patients treated and consultations) during the COVID-19 pandemic, from March to April 2020, comparing the activity in the same time period in 2018 and 2019. Results: In the period analyzed, a significant reduction in both the total number of procedures performed and of patients treated, respectively by 17 % and 16 % for the procedures and by 19 % and 20 % for patients treated compared to the same period of 2018 and 2019, respectively, was observed. A concomitant reduction in requests for TA consultation for new patients (both outpatients and inpatients) was observed, equal to 32 % and 21 % compared to 2018 and 2019, respectively. Conclusion: Many reasons determined the observed reduction in the TA activity during the recent COVID-19 outbreak. The AU itself was quickly reorganized in terms of location and supplies to allow for the appropriate COVID-19 patients care. Many non urgent cases, after multidisciplinary discussion between Clinicians and Apheresis Specialists, were deferred, maintaining close phone and e-mail contact with patients.

show abstract

Impact of COVID‐19 on blood centres in Zhejiang province China

Cited by 139 publications

References 12 publications

Blood transfusion utilization in hospitalized COVID‐19 patients

Blood transfusion utilization in hospitalized COVID‐19 patients

New blood donors in times of crisis: Increased donation willingness, particularly among people at high risk for attracting SARS-CoV-2

Impact of COVID-19 pandemic in the activity of a Therapeutic Apheresis unit in Italy

Contact Info

Product

Resources

About